[Archived Videos] 2023 Addiction Medicine Review Course


The 2023 Addiction Medicine Review Course reviews the essentials of addiction treatment while incorporating current evidence-based practices in this everchanging field. This activity was recorded live August 30 - September 2, 2023. 


As a part of your conference registration, you have access to two bonus CME sessions: 




Target Audience

• Physicians in all medical fields seeking to build their expertise in the full spectrum of diagnosis and management of substance use disorders.
• Physicians preparing for The American Board of Preventive Medicine Addiction Medicine Board Examination.
• Physicians in the field who want a refresher course based on the latest clinical research. 
• Any health care professionals, including but not limited to psychotherapists, nurses and drug abuse counselors, are involved in the treatment of patients with substance use disorders.

Learning Objectives

• Reflect on key principles of addiction medicine as outlined by the American Board of Preventative Medicine
• Describe the pharmacology and physiological effects of major substances of abuse, including intoxication and withdrawal states, as well as associated health consequences
• Summarize basic epidemiology and diagnosis of major substance use disorders
• Outline current evidence-based pharmacological treatment and non-pharmacologic interventions for major substance use disorders
• Examine emerging evidence around novel treatments and approaches to alcohol and opioid withdrawal, and frontiers of harm reduction

Course summary
Course opens: 
Course expires: 

Fentanyl Futures: Dynamics in supply, Use Patterns and Public Health Responses
Opioids & Fentanyl
Benzodiazepine-Sparing Protocol for Alcohol Withdrawal Panel
Co-occuring Mental Health Disorders
Treatments for ADHD in Susbstance Use Disorders Debate
Psychosocial Treatments
Spirituality Fireside Chats
Dopamine Fasting: An Early Intervention for Compulsive Overconsumption in the Digital Age
Adolescent Addiction Medicine Panel
Co-occuring Medical Presentations
Frontiers in Harm Reduction Panel
Ketamine in Buprenorphine Induction
Novel Ketamine Use in Addiction Medicine and Psychiatry
Ethics, Law, and Telehealth
Process Addiction

Arastou Aminzadeh, MD
Child and Adolescent Psychiatrist
BNI Treatment Center

Robert M. Anthenelli (he/him/his), MD
Professor of Psychiatry and Director, Pacific Treatment & Research Center @ UC San Diego
University of California, San Diego, School of Medicine

Raghu K. Appasani (he/him/his), MD
Integrative & Addiction Psychiatrist

Cullen Averill, MD
Emergency Medicine Physician
VA Loma Linda Healthcare System

Javier Ballester (he/him/his), MD
Addiction Psychiatrist
VA Salt Lake City

Leo Beletsky, JD MPH
Professor of Law and Health Sciences
UCSD Medical School/Northeastern

Christopher Blazes, MD
Associate Professor Dept of Psychiatry

Maurice Byrd (he/him/his), M.S., LMFT
Director of Training and Business Operations
Harm Reduction Therapy Center

Gilmore Chung (he/him/his), MD
Director of Addiction Medicine
Venice Family Clinic

Dan Ciccarone (he/him/his), MD, MPH
Justine Miner Professor of Addiction Medicine

Lucinda A. Grande (she/her/hers), MD
Pioneer Family Practice

Andrew A. Herring, MD
Chief of Addiction Medicine
Alameda Health System

Elizabeth F. Howell (she/her/hers), MD, MS
Professor of Psychiatry
University of Utah

Mitika Kanabar (she/her/hers), MD, MPH, FASAM, Dip ABLM
Physician Director of Education
Kaiser Permanente Antelope Valley

David Kan, MD, DFASAM
Private Practice of Psychiatry, Addiction Psychiatry and Forensic Psychiatry, Chief Medical Officer, Bright Heart Health
University of California, San Francisco

Waseem Khader, DO
Medical Director
Revive Pathway

Tipu Khan (he/him/his), MD, FAAFP, FASAM
Director of ADM and ADM Fellowship Director at Ventura County Medical Center; So. Cal. Medical Director for HealthRight360

Eve Lasswell (she/her/hers), PsyD
Assistant Clinical Professor
University of California San Diego

Anna Lembke, MD, FASAM
Director, Stanford University Addiction Medicine Fellowship and Chief, Stanford University Addiction Medicine Clinic
Stanford University School of Medicine

Barbara J. Mason (she/her/hers), PhD
The Scripps Research Institute

Julio Meza, MD
Addiction Medicine Fellowship Program Director

Johanna O'Flaherty (she/her/hers), PhD
JF Recovery, LLC

Siddarth Puri (he/him/his), MD
Associate Medical Director of Prevention
Los Angeles County Department of Public Health, Substance Abuse Prevention and Control

Soma Snakeoil (she/her/hers), None
Executive Director/CoFounder
The Sidewalk Project

Christy Sutherland (she/her/hers), MD CCFP (AM) dABAM
Medical Director
PHS Community Services Society

Mason S. Turner (he/him/his), MD, DFASAM
Senior Medical Director for Behavioral Health
Intermountain Healthcare

Gerrit I. van Schalkwyk (he/him/his), MD
Naval Medical Center, San Diego

Jonathan Watson (he/him/his), MD
Orange County Jail

Cory Weissman, MD
Assistant Professor, Medical Director of Interventional Psychiatry
University of California San Diego, Department of Psychiatry

Alexander S. Young (he/him/his), MD, MSHS

Tauheed Zaman, MD
UCSF and San Francisco VA Health Care System
San Francisco VA Medical Center



Please login or register to take this course.